# Anti-Restenosis After AMI by Erythropoietin

> **NCT00423020** · PHASE4 · UNKNOWN · sponsor: **Kyoto Prefectural University of Medicine** · enrollment: 72 (—)

## Conditions studied

- Acute Myocardial Infarction

## Interventions

- **DRUG:** Erythropoietin

## Key facts

- **NCT ID:** NCT00423020
- **Lead sponsor:** Kyoto Prefectural University of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 72 (—)
- **Last updated:** 2007-01-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00423020

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00423020, "Anti-Restenosis After AMI by Erythropoietin". Retrieved via MORVS 2026-10-22 from https://api.morvs.ai/clinical/NCT00423020. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*